Why is Gennex Lab. falling/rising?

As of 11-Jul, Gennex Laboratories Ltd is experiencing a price increase, currently at 14.59, reflecting a change of 0.26 or 1.81% upward. The stock has shown strong performance recently, with a consecutive gain over the last five days, resulting in a remarkable 17.95% return during this period. It has outperformed its sector by 1.23% today, and the delivery volume has surged by 626.72% against the five-day average, indicating rising investor participation. The company benefits from a low debt-to-equity ratio and healthy long-term growth, with operating profit increasing at an annual rate of 56.07%. However, the increase in pledged promoter shares to 23.87% raises some concerns about management efficiency, which is reflected in a low return on equity (ROE) of 8.70%.
In the broader market context, Gennex Laboratories Ltd has significantly outperformed the benchmark Sensex over the past week, which has declined by 1.12%, while the stock has risen by 17.95%. This contrast highlights the stock's strong short-term performance relative to the market. Despite a year-to-date decline of 10.71% compared to the Sensex's gain of 5.58%, the stock's recent upward trend suggests a positive shift in investor sentiment. The company's attractive valuation, trading at a discount to its peers, and a favorable PEG ratio of 0.6 further support the stock's rising price, despite some underlying concerns regarding management efficiency and recent flat financial results.